Stock research
OKUR OnKure Therapeutics, Inc.
Healthcare • Biotechnology
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of...…
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
1Y change
+103.92%
Range high
$5.27
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in OKUR?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $4.10
- Day High
- $4.33
- Day Low
- $3.88
- 52w High
- $5.38
- 52w Low
- $1.91
- Volume
- 249,938
- Avg Volume
- Beta
- 0.2984675
* TTM/most recent where available
Company
- Ticker
- OKUR
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Nicholas A. Saccomano
- Employees
- 45
- Website
- onkuretherapeutics.com
Key Metrics
- Market Cap
- 56.9M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).